Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer

OBJECTIVES: 18F-fluciclovine (fluciclovine) is an amino acid analog approved by the Food and Drug Administration for use as a radiotracer in positron emission tomography (PET) in men with biochemical recurrence of suspected prostate cancer. The purpose of this study was to investigate the initial in...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkas, Amy B., Green, Edward D., Thaggard, Anson L., Vijayakumar, Vani, Henegan, John C., Lirette, Seth T., Nittala, Mary R., Vijayakumar, Srinivasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Medicine & Medical Specialties
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560157/
https://www.ncbi.nlm.nih.gov/pubmed/34729614
http://dx.doi.org/10.14423/SMJ.0000000000001314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560157/
https://www.ncbi.nlm.nih.gov/pubmed/34729614
http://dx.doi.org/10.14423/SMJ.0000000000001314

Ejemplares similares